REFERENCES

Arck, P., P. J. Hansen, B. M. Jericevic, M.-P. Piccinni, and J. Szekeres-Bartho. 2007. Progesterone during pregnancy: Endocrine-immune cross talk in mammalian species and the role of stress. Journal of Reproductive Immunology 58(3):268–279.

Atif, F., I. Sayeed, T. Ishrat, and D. G. Stein. 2009. Progesterone with vitamin D affords better neuroprotection against excitotoxicity in cultured cortical neurons than progesterone alone. Molecular Medicine 15(9–10):328–336.

Buell, J. S., B. Dawson-Hughes, T. M. Scott, D. E. Weiner, G. E. Dallal, W. Q. Qui, P. Bergethon, I. H. Rosenberg, M. F. Folstein, S. Patz, R. A. Bhadelia, and K. L. Tucker. 2010. 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 74(1):18–26.

Cannon, J. G. 1998. Adaptive interactions between cytokines and the hypothalamic-pituitary-gonadal axis. Annals of the New York Academy of Sciences 856:234–242.

Cekic, M., S. M. Cutler, J. W. vanLandingham, and D. G. Stein. 2009. Vitamin D deficiency reduces the benefits of progesterone treatment after brain injury in aged rats. Neurobiology of Aging. Published electronically May 29, 2009. doi:10.1016/jneurobiolaging.2009.04.017.

Chesik, D., and J. De Keyser. 2010. Progesterone and dexamethasone differentially regulate the IGF system in glial cells. Neuroscience Letters 468(3):178–182.

Eyles, D. W., S. Smith, R. Kinobe, M. Hewison, and J. J. McGrath. 2005. Distribution of the vitamin D receptor and 1α-hydroxylase in human brain. Journal of Chemical Neuroanatomy 29(1):21–30.

Fitzpatrick, L. A., and A. Good. 1999. Micronized progesterone: Clinical indications and comparison with current treatments. Fertility and Sterility 72(3):389–397.

Fleet, J. C. 2007. What have genomic and proteomic approaches told us about vitamin D and cancer? Nutrition Reviews 65(8):S127–S130.

Holick, M. F. 2007. Vitamin D deficiency. The New England Journal of Medicine 357(3):266–281.

IOM (Institute of Medicine). 2010. Dietary Reference Intakes for calcium and vitamin D. Washington, DC: The National Academies Press.

Kajta, M., D. Makarewicz, E. Zieminska, D. Jantas, H. Domin, W. Lason, A. Kutner, and J. W. Lazarewicz. 2009. Neuroprotection by co-treatment and post-treating with calcitriol following the ischemic and excitotoxic insult in vivo and in vitro. Neurochemistry International 55(5):265–274.

Labombarda, F., S. L. Gonzalez, A. Lima, P. Roig, R. Guennoun, M. Schumacher, and A. F. de Nicola. 2009. Effects of progesterone on oligodendrocyte progenitors, oligodendrocyte transcription factors, and myelin proteins following spinal cord injury. Glia 57(8):884–897.

Leskiewicz, M., B. Budziszewska, A. Basta-Kaim, A. Zajac, M. Kacinski, and W. Lason. 2006. Effects of neurosteroids on neuronal survival: Molecular basis and clinical perspectives. Acta Neurobiologiae Experimentalis 66(4):359–367.

Levenson, C. W., and S. M. Figueirôa. 2008. Gestational vitamin D deficiency: Long-term effects on the brain. Nutrition Reviews 66(12):726–729.

Martini, L. A., and R. J. Wood. 2008. Vitamin D and blood pressure connection: Update on epidemiologic, clinical, and mechanistic evidence. Nutrition Reviews 66(5):291–297.

Micevych, P., and K. Sinchak. 2008. Minireview: Synthesis and function of hypothalamic neuroprogesterone in reproduction. Endocrinology 149(6):2739–2742.

Stein, D. G. 2008. Progesterone exerts neuroprotective effects after brain injury. Brain Research Reviews 57(2):386–397.

Wagner, C. K. 2008. Minireview: Progesterone receptors and neural development: A gap between bench and bedside? Endocrinology 149(6):2743–2749.

Wang, Y., Y. H. Chiang, T. P. Su, T. Hayashi, M. Morales, B. J. Hoffer, and S. Z. Lin. 2000. Vitamin D-3 attenuates cortical infarction induced by middle cerebral arterial ligation in rats. Neuropharmacology 39(5):873–880.

Wood, R. J. 2008. Vitamin D and adipogenesis: New molecular insights. Nutrition Reviews 66(1):40–46.

Wright, D. W., J. C. Ritchie, R. E. Mullins, A. L. Kellermann, and D. D. Denson. 2005. Steady-state serum concentrations of progesterone following continuous intravenous infusion in patients with acute moderate to severe traumatic brain injury. Journal of Clinical Pharmacology 45(6):640–648.

Wright, D. W., A. L. Kellermann, V. S. Hertzberg, P. L. Clark, M. Frankel, F. C. Goldstein, J. P. Salomone, L. L. Dent, O. A. Harris, D. S. Ander, D. W. Lowery, M. M. Patel, D. D. Denson, A. B. Gordon, M. M. Wald, S. Gupta, S. W. Hoffman, and D. G. Stein. 2007. ProTECT: A randomized clinical trial of progesterone for acute traumatic brain injury. Annals of Emergency Medicine 49(4):391–402.

Xiao, G., J. Wei, W. Yan, W. Wang, and Z. Lu. 2008. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: A randomized controlled trial. Critical Care 12(2):R61.

Zava, D. T., C. M. Dollbaum, and M. Blen. 1998. Estrogen and progestin bioactivity of foods, herbs and spices. Proceedings of the Society for Experimental Biology and Medicine 217(3):369–378.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement